Skip to content

ERBECRYO 2 Cryosurgical Unit and Flexible Cryoprobe

by Erbe Elektromedizin GmbH

510(k) K253230Ref 20402-411

Active European Union and United States. Also listed in GUDID (US).

CE MDR 510(k)

Valid until

Not listed

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

4 ongoing

This device is named in the recall

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, FDA 510(k), GUDID, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR EUDAMED Number4050147CryoProbe-SU-VT Basic UDI-DI 04050147021839UDI-DIDate13 May 2026RegisteredStatusActive
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK253230 Date22 Apr 2026ClearedStatusActive
United StatesGUDID listing GUDID Number04050147021839 UDI-DI Date7 Feb 2020ListedStatusListed GUDID: in commercial distribution

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Recalls

4 recalls · 4 ongoing · FDA

    • Ongoing Z-2938-2026 FDA Class II initiated 26 Jun 2026

    A strong pull on the high-pressure transfer hose of cryosurgical unit may lead to pneumatic short circuit between he gas inlet and the connector resulting in CO2 leaking into the return path, leading to excessive pressure causing the cryoprobe to rupture.

  • 3 recalls, same reason

    • Ongoing Z-1566-2026 FDA Class I initiated 12 Feb 2026
    • Ongoing Z-1568-2026 FDA Class I initiated 12 Feb 2026
    • Ongoing Z-1567-2026 FDA Class I initiated 12 Feb 2026

    Probes may rupture/burst during activation

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k) · GUDID

Full name
ERBECRYO 2 Cryosurgical Unit and Accessories: ERBECRYO 2 cryosurgical unit; Erbe Flexible Cryoprobe
Trade Name
Flexible Cryoprobe EUDAMED
Erbe GUDID
Generic Name
Endoscopic cryosurgical probe, single-use
Device Name
Cryosurgery flex. probes, SU
Model / Ref / Catalog
20402-411
Primary DI / UDI-DI
04050147021839
Basic UDI-DI
4050147CryoProbe-SU-VT
Direct Marketing DI
04050147021839
510(k) Number
FDA Product Code
GEH
EMDN Code
Z120102 Cryosurgery equipment
GMDN Term
Endoscopic cryosurgical probe, single-use
Device Class
Class IIb EUDAMED
Class II 510(k)GUDID
Regulation
21 CFR Part 878.4350
EU market of registration
Germany
Advisory Committee
General, Plastic Surgery
FDA Decision
SESE Substantially Equivalent
GUDID distribution status
In Commercial Distribution
Size
Length — 1150 Millimeter

Truth per registry

3 sources · 2 fields differ

FieldEUDAMED510(k)GUDID
510(k) NumberEUDAMED
—
510(k)
K253230
GUDID
K190651
Device ClassEUDAMED
Class IIb
510(k)
Class II
GUDID
Class II

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The ERBECRYO 2 Cryosurgical Unit is a cryosurgical device designed for controlled tissue freezing. It employs cryotherapy to destroy abnormal tissue, such as tumors or benign lesions, through rapid freezing and thawing cycles. The system integrates a cryosurgical unit with flexible cryoprobes to deliver precise cryoablation treatments in surgical settings.

This device is supplied as a reusable cryosurgical unit paired with single-use flexible cryoprobes, intended for use in operating rooms or clinical environments. It operates under sterile conditions and is classified as a Class II medical device under FDA regulations (510(k) clearance and MDR authorization). The system includes multiple probe sizes and accessories, with MRI safety considerations noted in its specifications. Authorized for general and plastic surgery applications, it adheres to regulatory standards for cryosurgical interventions.

Other devices from Erbe Elektromedizin GmbH

See all devices from Erbe Elektromedizin GmbH →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of tissues or conditions is the ERBECRYO 2 system primarily used to treat in surgical settings?

    The ERBECRYO 2 Cryosurgical Unit is designed for controlled tissue freezing to destroy abnormal tissues such as tumors or benign lesions. It is specifically authorized for use in general and plastic surgery applications, where cryoablation is employed to target and eliminate unwanted tissue through rapid freezing and thawing cycles.

  • How is the ERBECRYO 2 system supplied, and are the cryoprobes reusable or single-use?

    The ERBECRYO 2 system is supplied as a reusable cryosurgical unit paired with single-use flexible cryoprobes. This setup ensures sterile conditions for each procedure while allowing the main unit to be reused across multiple applications, reducing operational costs and waste.

  • Does the ERBECRYO 2 system include multiple probe sizes, and if so, what are the key considerations for selecting the right one?

    Yes, the ERBECRYO 2 system includes multiple probe sizes to accommodate different clinical needs. The selection of the appropriate probe size depends on the specific anatomical location and the size of the tissue targeted for ablation. The flexible design of the probes allows for precise delivery in various surgical settings, including areas where rigid probes may be less effective.

  • What regulatory pathways has the ERBECRYO 2 system undergone, and what does this mean for its use in clinical environments?

    The ERBECRYO 2 system has undergone FDA 510(k) clearance and MDR (Medical Device Regulation) authorization, confirming its compliance with regulatory standards for cryosurgical interventions. This means the device has been evaluated for safety and effectiveness, allowing authorized use in clinical environments where controlled tissue freezing is required, such as in general and plastic surgery.

  • Are there any special considerations for storing or handling the ERBECRYO 2 system and its accessories?

    While the device data does not specify storage conditions, the system is designed for use in sterile operating room environments. The single-use cryoprobes must be handled under sterile conditions to prevent contamination. The reusable cryosurgical unit should be cleaned and maintained according to manufacturer guidelines to ensure proper functionality and longevity, particularly given its intended use in surgical settings.

Properties

  • Sterile
  • Single Use
  • Prescription Use
  • Lot / Batch Number
  • Expiration Date

Other properties (19)

  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No
  • Over-the-Counter: No
  • Convenience Kit: No
  • Combination Product: No
  • HCT/P: No
  • Premarket Exempt: No
  • Serial Number: No
  • Manufacturing Date: No